Dortmund, Germany

Kerstin Pauli

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerstin Pauli. Retrieved from https://idiyas.com/inventor/kerstin-pauli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kerstin Pauli: Innovator in Pharmaceutical Formulations

Introduction

Kerstin Pauli is a notable inventor based in Dortmund, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations that enhance bioavailability.

Latest Patents

Kerstin Pauli holds 1 patent for her innovative work on pharmaceutical forms with improved pharmacokinetic properties. Her patent focuses on novel drug formulations of vardenafil that dissolve rapidly in the mouth, leading to increased bioavailability and a plateau-like plasma concentration profile. This advancement has the potential to improve patient outcomes significantly.

Career Highlights

Throughout her career, Kerstin has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to develop and refine her expertise in drug formulation.

Collaborations

Kerstin has collaborated with esteemed colleagues such as Peter Serno and Roland Heinig. These partnerships have contributed to her innovative work and the successful development of her patented formulations.

Conclusion

Kerstin Pauli's contributions to pharmaceutical innovations demonstrate her commitment to improving drug delivery systems. Her work continues to influence the field and enhance the effectiveness of treatments available to patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…